ARTERRA BIOSCIENCE (ARBS.MI)

EUR 2.24

(0.0%)

EBITDA Summary of ARTERRA BIOSCIENCE

ARTERRA BIOSCIENCE's latest annual EBITDA in 2023 was 1.59 Million EUR , up 77.44% from previous year.
ARTERRA BIOSCIENCE's latest quarterly EBITDA in 2024 Q2 was 592.74 Thousand EUR , down 0.0% from previous quarter.
ARTERRA BIOSCIENCE reported an annual EBITDA of 2.13 Million EUR in 2022, down -7.6% from previous year.
ARTERRA BIOSCIENCE reported an annual EBITDA of 1.76 Million EUR in 2021, up 287.54% from previous year.
ARTERRA BIOSCIENCE reported a quarterly EBITDA of 1.22 Million EUR for 2023 Q4, down 0.0% from previous quarter.
ARTERRA BIOSCIENCE reported a quarterly EBITDA of N/A for 2023 FY, up 77.44% from previous quarter.

Annual EBITDA Chart of ARTERRA BIOSCIENCE (2023 - 2017)

Historical Annual EBITDA of ARTERRA BIOSCIENCE (2023 - 2017)

Year	EBITDA	EBITDA Growth
2023	1.59 Million EUR	77.44%
2022	2.13 Million EUR	-7.6%
2021	1.76 Million EUR	287.54%
2020	1.6 Million EUR	-42.73%
2019	1.23 Million EUR	-25.05%
2018	607.95 Thousand EUR	9.87%
2017	539.3 Thousand EUR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	592.74 Thousand EUR	0.0%
2023 Q4	1.22 Million EUR	0.0%
2023 FY	- EUR	77.44%
2023 Q2	-292.74 Thousand EUR	0.0%
2022 FY	- EUR	-7.6%
2022 Q2	820.7 Thousand EUR	0.0%
2022 Q4	70.29 Thousand EUR	0.0%
2021 Q2	130.14 Thousand EUR	0.0%
2021 FY	- EUR	287.54%
2021 Q4	688.56 Thousand EUR	0.0%
2020 Q4	125.5 Thousand EUR	0.0%
2020 Q2	124.96 Thousand EUR	0.0%
2020 FY	- EUR	-42.73%
2019 Q3	315.84 Thousand EUR	-17.18%
2019 FY	- EUR	-25.05%
2019 Q4	68.92 Thousand EUR	-78.18%
2019 Q2	381.36 Thousand EUR	0.0%
2018 Q4	473.96 Thousand EUR	0.0%
2018 FY	- EUR	9.87%
2018 Q2	166.05 Thousand EUR	0.0%
2017 FY	- EUR	0.0%

Peer EBITDA Comparison of ARTERRA BIOSCIENCE

Name	EBITDA	EBITDA Difference
Philogen S.p.A.	-2.04 Million EUR	177.745%
Ulisse Biomed S.p.A.	-2.14 Million EUR	174.284%